Spots Global Cancer Trial Database for DERM US and EU Validation Study
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: DERM US and EU Validation Study
Official Title: A Clinical Validation Study to Demonstrate the Effectiveness of an Artificial Intelligence Algorithm (DERM) to Identify Skin Cancer in Patients Undergoing a Skin Biopsy
Study ID: NCT05126173
Study Description
Brief Summary: This study aims establish the effectiveness of Image Analysing Algorithm (DERM) to identify melanoma, Squamous Cell Carcinoma (SCC) and Basal Cell Carcinoma (BCC) when used to analyse dermoscopic images of skin lesions within the US and European population.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Stanford university, Redwood City, California, United States
Vista Health Research, LLC, Miami, Florida, United States
Dorisca Research Consulting, LLC, Miami, Florida, United States
Northwestern University, Chicago, Illinois, United States
ALLCUTIS Research, LLC, Beverly, Massachusetts, United States
Allcutis Research, Methuen, Massachusetts, United States
Universal Dermatology, PLLC, Fairport, New York, United States
University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States
Alpesh D. Desai, DO, PLLC, a Houston company institution, Houston, Texas, United States
University of Utah, Salt Lake City, Utah, United States
Universitaria Di Bologna, Bologna, , Italy
Dermatology University of Florence, Firenze, , Italy
Università degli Studi di Modena e Reggio Emilia, Modena, , Italy
University of Campania, Napoli, , Italy
Università del Piemonte Orientale, Novara, , Italy
UOSD Dermatology Oncology, Roma, , Italy
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
